Prevalence and prognostic impact of comorbidities and peripheral blood indices in sarcomas
Background The prognostic impact of comorbidities in patients with sarcomas is not well defined. The aims of this study were to examine the implications of comorbidities and abnormal peripheral blood indices in patients with sarcomas.Methods A population-based database was assembled to extract patie...
Main Authors: | Teresa Tse, Carlos King Ho Wong, Herbert Ho-fung Loong, Yihui Wei, Sampson Sui Chun Kwan, Yingjun Zhang, Yat-Ming Lau, Linda K S Leung, Gordon C H Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | ESMO Open |
Online Access: | https://esmoopen.bmj.com/content/5/6/e001035.full |
Similar Items
-
Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma
by: Zhao H, et al.
Published: (2016-03-01) -
Primary Chest Wall Sarcoma: Surgical Outcomes and Prognostic Factors
by: Ilkun Park, et al.
Published: (2019-10-01) -
Prognostic Factors Associated with Clear Cell Sarcoma in 14 Chinese Patients
by: HL Lee, et al.
Published: (2014-08-01) -
Treatment Outcomes and Prognostic Factors of Patients With Primary Spinal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors
by: Jun Chen, et al.
Published: (2019-06-01) -
Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis
by: Myrthe P. P. van Herk-Sukel, et al.
Published: (2012-01-01)